Differences in response to reperfusion therapies in acute stroke between men and women: Mediated by sex or by chance? [12]

Stroke

Volumn 37, Issue 12, 2006, Pages 2878-2879

  Kent, David M ^a   Hill, Michael D ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

BLOOD CLOT LYSIS; CLINICAL TRIAL; DATA ANALYSIS; DRUG RESPONSE; FALSE POSITIVE RESULT; FEMALE; FIBRINOLYTIC THERAPY; GENDER; HUMAN; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; STROKE;

CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; REPERFUSION; SEX CHARACTERISTICS;

EID: 33845417443     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000248166.30486.4f     Document Type: Letter

References (12)

1. Hayward RA, Kent DM, Vijan S, Hofer TP. Reporting clinical trial results to inform providers, payers, and consumers. Health Affairs. 2005;24:1571-1581.
2. Hayward RA, Kent DM, Vijan S, Hofer TP. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Medical Research Methodology. 2006;6:18.
3. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet. 365:256-265.
4. Lofgren B, Nyberg L, Osterlind PO, Gustafson Y. In-patient rehabilitation after stroke: outcome and factors associated with improvement. Disability & Rehabilitation. 1998;20:55-61.
5. Weimar C, Ziegler A, Konig IR, Diener HC. Predicting functional outcome and survival after acute ischemic stroke. J Neurol. 2002;249:888-895.
6. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, Asplund K; Riks-Stroke Collaboration. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003;34:1970-1975.
7. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D; European BIOMED Study of Stroke Care Group. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke. 2003;34:1114-1119.
8. Roquer J, Campello AR, Gomis M. Sex differences in first ever acute stroke. Stroke. 2003;34:1581-1585.
9. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, Cheung AM; Investigators of the Registry of the Canadian Stroke Network. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke. 2005;36:809-814.
10. Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A; International Stroke Trial Collaborative Group. Influence of gender on baseline features and clinical outcomes among 17, 370 patients with confirmed ischaemic stroke in the international stroke trial Neuroepidemiology. 2005;24:123-128.
11. Kent DM, Hayward RA, Griffith JL, Vijan S, Beshansky JR, Califf RM, Selker HP. An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase. Am J Med. 2002;113:104-111.
12. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. Lancet. 1999;353:2105-2110.